Crossmark

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Crossref DOI link: https://doi.org/10.1186/s13045-018-0649-6

Published Online: 2018-08-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Cen

Chen, Feng

Kong, Danqing

Ma, Qinfen

Dai, Haiping

Yin, Jia

Li, Zheng

Chen, Jia

Zhu, Xiaming

Mao, Xinliang

Wu, Depei

Tang, Xiaowen
Funding

Funding for this research was provided by:

National Key R&D Program of China (2016YFC0902800)

National Natural Science Foundation of China (81270645)

Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)

Frontier Clinical Technical Project Of the Science and Technology Department of Jiangsu Province (BE2017655)

Jiangsu Provincial Medical Talent (ZDRCA2016045)
License Information

Text and Data Mining valid from 2018-08-16
More Information

Article History

Received: 26 May 2018

Accepted: 8 August 2018

First Online: 16 August 2018

Ethics approval and consent to participate

: This study was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.